Massachusetts Wealth Management Purchases 313 Shares of iShares Biotechnology ETF $IBB

Massachusetts Wealth Management increased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 12.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,803 shares of the financial services provider’s stock after purchasing an additional 313 shares during the quarter. Massachusetts Wealth Management’s holdings in iShares Biotechnology ETF were worth $355,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Moors & Cabot Inc. lifted its stake in shares of iShares Biotechnology ETF by 2.0% during the 1st quarter. Moors & Cabot Inc. now owns 29,053 shares of the financial services provider’s stock worth $3,716,000 after purchasing an additional 558 shares during the last quarter. IFP Advisors Inc lifted its stake in shares of iShares Biotechnology ETF by 23.9% during the 1st quarter. IFP Advisors Inc now owns 19,849 shares of the financial services provider’s stock worth $2,539,000 after purchasing an additional 3,831 shares during the last quarter. N.E.W. Advisory Services LLC purchased a new stake in shares of iShares Biotechnology ETF during the 1st quarter worth $45,000. Kingswood Wealth Advisors LLC lifted its stake in shares of iShares Biotechnology ETF by 81.2% during the 1st quarter. Kingswood Wealth Advisors LLC now owns 4,532 shares of the financial services provider’s stock worth $570,000 after purchasing an additional 2,031 shares during the last quarter. Finally, John G Ullman & Associates Inc. purchased a new stake in shares of iShares Biotechnology ETF during the 1st quarter worth $230,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $151.99 on Thursday. iShares Biotechnology ETF has a 1-year low of $107.43 and a 1-year high of $153.01. The business has a fifty day moving average price of $140.21 and a 200 day moving average price of $130.36.

iShares Biotechnology ETF Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were paid a $0.0828 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.